TECH Sell 01.07.2024 14:11
Pfizer Inc.: Murrey analysis
Since mid-April, shares of Pfizer Inc., the largest American pharmaceutical company, have been trying to resume growth. At the beginning of last month, they reached the pivot level of 29.69 (Murrey level [6/8]) but could not break higher and corrected to the area of 27.34 (Murrey level [3/8]).
Indicators
Overall recommendation Wait
Overall recommendation Active Sell
Overall recommendation Wait
Overall recommendation Sell
Overall recommendation Sell
Overall recommendation Sell
Overall recommendation Buy